|
CA2596506C
(en)
|
2005-02-09 |
2021-04-06 |
Avi Biopharma, Inc. |
Antisense composition and method for treating muscle atrophy
|
|
US8236557B2
(en)
*
|
2008-05-28 |
2012-08-07 |
University Of Missouri-Columbia |
Hybrid-AAV vectors to deliver large gene expression cassette
|
|
WO2010093784A2
(en)
|
2009-02-11 |
2010-08-19 |
The University Of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
WO2011088081A1
(en)
|
2010-01-12 |
2011-07-21 |
The University Of North Carolina At Chapel Hill |
Restrictive inverted terminal repeats for viral vectors
|
|
WO2011097456A2
(en)
|
2010-02-05 |
2011-08-11 |
The University Of North Carolina At Chapel Hill |
Compositions and methods for enhanced parvovirus transduction
|
|
DK2673289T3
(da)
|
2011-02-10 |
2023-07-24 |
Univ North Carolina Chapel Hill |
Virusvektorer med modificerede transduktionsprofiler og fremgangsmåder til fremstilling og anvendelse deraf
|
|
US20130085139A1
(en)
|
2011-10-04 |
2013-04-04 |
Royal Holloway And Bedford New College |
Oligomers
|
|
WO2013075008A1
(en)
*
|
2011-11-16 |
2013-05-23 |
University Of Florida Research Foundation Inc. |
Aav dual vector systems for gene therapy
|
|
CN103405774A
(zh)
*
|
2012-10-24 |
2013-11-27 |
尹海芳 |
一种新型药物靶向运输辅助剂
|
|
US20140140969A1
(en)
*
|
2012-11-20 |
2014-05-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for muscular dystrophies
|
|
US9624282B2
(en)
|
2012-11-26 |
2017-04-18 |
The Curators Of The University Of Missouri |
Microdystrophin peptides and methods for treating muscular dystrophy using the same
|
|
EP2970966A4
(en)
|
2013-03-15 |
2016-10-26 |
Univ North Carolina |
SYNTHETIC ADENOASSOZED VIRUS INVERTED REPEAT SEQUENCES
|
|
EP2968605B1
(en)
|
2013-03-15 |
2022-07-27 |
The University of North Carolina At Chapel Hill |
Methods and compositions for dual glycan binding aav vectors
|
|
EP3245220B1
(en)
|
2015-01-14 |
2023-09-20 |
The University of North Carolina at Chapel Hill |
Methods and compositions for targeted gene transfer
|
|
IL315273A
(en)
|
2015-01-16 |
2024-10-01 |
Univ Washington |
Novel micro-dystrophins and related methods of use
|
|
EP3258961A4
(en)
|
2015-02-20 |
2018-08-22 |
Board of Regents, The University of Texas System |
Methods and compositions for attenuated chlamydia as vaccine and vector
|
|
GB201507842D0
(en)
*
|
2015-05-07 |
2015-06-17 |
New Royal Holloway & Bedford |
Production of large-sized microdystrophins in an AAV-based vector configuration
|
|
IL292830B2
(en)
|
2015-09-28 |
2023-06-01 |
Univ Florida |
Methods and compositions for stealth virus antibody vectors
|
|
EP3359668A4
(en)
|
2015-10-09 |
2019-06-05 |
Sarepta Therapeutics, Inc. |
COMPOSITIONS AND METHODS OF TREATING DUCHENNE MUSCLE DYSTROPHY AND ASSOCIATED ILLNESSES THEREOF
|
|
IL259441B2
(en)
|
2015-11-16 |
2024-01-01 |
Res Inst Nationwide Childrens Hospital |
Materials and methods for treatment of titin-based myopathies and other titinopaties
|
|
US11124546B2
(en)
|
2015-12-14 |
2021-09-21 |
The University Of North Carolina At Chapel Hill |
Modified capsid proteins for enhanced delivery of parvovirus vectors
|
|
MA45477A
(fr)
|
2016-04-15 |
2019-02-20 |
Res Inst Nationwide Childrens Hospital |
Administration à vecteurs de virus adéno-associé de microarn-29 et micro-dystrophine pour traiter la dystrophie musculaire
|
|
JP7079733B2
(ja)
|
2016-04-15 |
2022-06-02 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
β－サルコグリカン及びマイクロＲＮＡ－２９のアデノ随伴ウイルスベクター送達ならびに筋ジストロフィーの治療
|
|
CA2971303A1
(en)
*
|
2016-06-21 |
2017-12-21 |
Bamboo Therapeutics, Inc. |
Optimized mini-dystrophin genes and expression cassettes and their use
|
|
WO2017223128A1
(en)
*
|
2016-06-21 |
2017-12-28 |
The Curators Of The University Of Missouri |
Modified dystrophin proteins
|
|
EP3491008A2
(en)
|
2016-07-26 |
2019-06-05 |
BioMarin Pharmaceutical Inc. |
Novel adeno-associated virus capsid proteins
|
|
ES2982489T3
(es)
|
2016-08-19 |
2024-10-16 |
Univ Florida |
Composiciones para el tratamiento de afecciones que utilizan virus adeno-asociados recombinantes autocomplementarios
|
|
EP3551650A4
(en)
|
2016-12-07 |
2020-07-08 |
The University of Florida Research Foundation Incorporated |
IL-1RA ADNC
|
|
CN110914419A
(zh)
|
2017-03-10 |
2020-03-24 |
吉尼松公司 |
糖原贮积病iii的治疗
|
|
CN110770346B
(zh)
|
2017-03-15 |
2024-01-12 |
北卡罗来纳-查佩尔山大学 |
多倍体腺相关病毒载体及其制备和使用方法
|
|
EP3596112A2
(en)
|
2017-03-17 |
2020-01-22 |
Newcastle University |
Adeno-associated virus vector delivery of a fragment of micro-dystrophin to treat muscular dystrophy
|
|
KR20230167138A
(ko)
|
2017-05-05 |
2023-12-07 |
유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 |
오토펄린을 발현시키기 위한 조성물 및 방법
|
|
JP7213238B2
(ja)
|
2017-10-18 |
2023-01-26 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
筋ジストロフィーを治療するための筋特異的マイクロジストロフィンのアデノ随伴ウイルスベクター送達
|
|
CN119770682A
(zh)
|
2018-01-31 |
2025-04-08 |
国家儿童医院研究所 |
2c型肢带型肌营养不良的基因疗法
|
|
CN112041442A
(zh)
|
2018-02-28 |
2020-12-04 |
北卡罗来纳大学查佩尔希尔分校 |
用于逃避抗体的病毒载体的方法和组合物
|
|
KR20210006358A
(ko)
|
2018-04-03 |
2021-01-18 |
스트라이드바이오 인코포레이티드 |
안 조직을 표적으로 하기 위한 바이러스 벡터
|
|
AU2019247746B2
(en)
|
2018-04-03 |
2024-08-15 |
Ginkgo Bioworks, Inc. |
Antibody-evading virus vectors
|
|
AU2019247748A1
(en)
|
2018-04-03 |
2020-10-08 |
Ginkgo Bioworks, Inc. |
Antibody-evading virus vectors
|
|
JP7575273B2
(ja)
|
2018-04-16 |
2024-10-29 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
デュシェンヌ型筋ジストロフィーを治療するための組成物及び方法
|
|
JP7331011B2
(ja)
|
2018-04-27 |
2023-08-22 |
デシベル セラピューティクス インコーポレイテッド |
ミオシン１５プロモーター及びその使用
|
|
US11660353B2
(en)
|
2018-04-27 |
2023-05-30 |
Decibel Therapeutics, Inc. |
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
|
KR20210008501A
(ko)
|
2018-05-09 |
2021-01-22 |
바이오마린 파머수티컬 인크. |
페닐케톤뇨증을 치료하는 방법
|
|
TW202005978A
(zh)
|
2018-05-14 |
2020-02-01 |
美商拜奧馬林製藥公司 |
新穎肝靶向腺相關病毒載體
|
|
US10758629B2
(en)
|
2018-05-29 |
2020-09-01 |
Sarepta Therapeutics, Inc. |
Exon skipping oligomer conjugates for muscular dystrophy
|
|
JP7646362B2
(ja)
*
|
2018-06-18 |
2025-03-17 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
筋ジストロフィーを治療するための筋肉特異的マイクロジストロフィンのアデノ随伴ウイルスベクターデリバリー
|
|
WO2019246544A2
(en)
|
2018-06-22 |
2019-12-26 |
Asklepios Biopharmaceutical, Inc. |
Vectors for gene delivery that persist within cells
|
|
MX2020014119A
(es)
|
2018-06-29 |
2021-06-18 |
Res Inst Nationwide Childrens Hospital |
Productos y métodos de virus adenoasociado recombinante para el tratamiento de la distrofia muscular de cinturas 2a.
|
|
US12188041B2
(en)
|
2018-11-01 |
2025-01-07 |
University Of Florida Research Foundation, Incorporated |
Codon optimized otoferlin AAV dual vector gene therapy
|
|
EP3921032A4
(en)
|
2019-02-08 |
2022-11-30 |
Decibel Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS
|
|
CA3129422A1
(en)
|
2019-02-08 |
2020-08-13 |
Decibel Therapeutics, Inc. |
Myosin 15 promoters and uses thereof
|
|
SG11202109113TA
(en)
|
2019-02-26 |
2021-09-29 |
Res Inst Nationwide Childrens Hospital |
Adeno-associated virus vector delivery of b-sarcoglycan and the treatment of muscular dystrophy
|
|
MX2021011468A
(es)
|
2019-03-21 |
2021-12-15 |
|
Vectores de virus adenoasociados recombinantes.
|
|
CN113677697B
(zh)
*
|
2019-03-25 |
2024-06-04 |
吉尼松公司 |
使用重叠的aav载体生产大型拟抗肌萎缩蛋白
|
|
WO2020219656A1
(en)
|
2019-04-26 |
2020-10-29 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for dual glycan binding aav2.5 vector
|
|
EP3976806A1
(en)
|
2019-05-30 |
2022-04-06 |
Solidus Biosciences, Inc. |
Recombinant herpesvirales vector
|
|
BR112022000397A8
(pt)
*
|
2019-07-10 |
2023-02-28 |
Univ Washington |
Imuno-direcionamento não viral
|
|
SI4017871T1
(sl)
|
2019-08-21 |
2024-06-28 |
Research Institute At Nationwide Children's Hospital |
Dostava alfa-sarkoglikana z adeno povezanim virusnim vektorjem in zdravljenje mišične distrofije
|
|
WO2021076925A1
(en)
|
2019-10-17 |
2021-04-22 |
Stridebio, Inc. |
Adeno-associated viral vectors for treatment of niemann-pick disease type c
|
|
CA3155381A1
(en)
|
2019-11-06 |
2021-05-14 |
Association Institut De Myologie |
Combined therapy for muscular diseases
|
|
CA3159516A1
(en)
*
|
2019-11-28 |
2021-06-03 |
Chunping Qiao |
Microdystrophin gene therapy constructs and uses thereof
|
|
IL295741A
(en)
|
2020-04-01 |
2022-10-01 |
Univ Florida |
Dual aav-myo7a vectors with improved safety for the treatment of ush1b
|
|
TW202206447A
(zh)
|
2020-04-29 |
2022-02-16 |
美商必治妥美雅史谷比公司 |
具血影蛋白(spectrin)融合結構域之微型化肌肉萎縮蛋白及其用途
|
|
IL300717A
(en)
|
2020-08-19 |
2023-04-01 |
Sarepta Therapeutics Inc |
ADENO-related virus vectors for the treatment of RETT syndrome
|
|
WO2022076750A2
(en)
|
2020-10-07 |
2022-04-14 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for cns or muscle delivery
|
|
WO2022093769A1
(en)
|
2020-10-28 |
2022-05-05 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for dual glycan binding aav2.5 vector
|
|
ES3001131T3
(es)
|
2020-10-28 |
2025-03-04 |
Univ North Carolina Chapel Hill |
Métodos y composiciones para la unión dual de glicanos al vector de AAV2.5
|
|
TW202242124A
(zh)
|
2021-01-14 |
2022-11-01 |
美商史崔德生物公司 |
靶向ｔ細胞之ａａｖ載體
|
|
EP4320139A1
(en)
|
2021-04-05 |
2024-02-14 |
Solid Biosciences Inc. |
Recombinant herpesvirales vector
|
|
EP4323015A4
(en)
|
2021-04-16 |
2025-10-22 |
Askbio Inc |
RATIONALLY POLYPLOID AAV VIRIONS CROSS THE BLOOD-BRAIN BARRIER AND TRIGGER A REDUCED HUMORAL RESPONSE
|
|
WO2022232141A1
(en)
*
|
2021-04-26 |
2022-11-03 |
Regenxbio Inc. |
Microdystrophin gene therapy administration for treatment of dystrophinopathies
|
|
WO2023056311A1
(en)
*
|
2021-09-28 |
2023-04-06 |
University Of Florida Research Foundation, Incorporated |
Gene therapy for duchenne muscular dystrophy
|
|
WO2023060269A1
(en)
|
2021-10-07 |
2023-04-13 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for targeted delivery
|
|
CN115960946B
(zh)
*
|
2021-10-09 |
2026-02-13 |
中国科学院分子植物科学卓越创新中心 |
调节植物镁离子吸收和转运的方法
|
|
US12285497B2
(en)
|
2021-10-15 |
2025-04-29 |
Research Institute At Nationwide Children's Hospital |
Self-complementary adeno-associated virus vector and its use in treatment of muscular dystrophy
|
|
EP4466028A1
(en)
*
|
2022-01-17 |
2024-11-27 |
Dinaqor AG |
Gene therapy composition and treatment for dystrophin-related cardiomyopathy
|
|
EP4215614A1
(en)
|
2022-01-24 |
2023-07-26 |
Dynacure |
Combination therapy for dystrophin-related diseases
|
|
WO2023150687A1
(en)
|
2022-02-04 |
2023-08-10 |
Ginkgo Bioworks, Inc. |
Recombinant adeno-associated virus vectors, and methods of use thereof
|
|
US20250288641A1
(en)
*
|
2022-04-27 |
2025-09-18 |
The Curators Of The University Of Missouri |
Micro-dystrophin for heart protection
|
|
WO2024124019A2
(en)
|
2022-12-07 |
2024-06-13 |
Ginkgo Bioworks, Inc. |
Aav vectors targeting hematopoietic stem cells
|
|
EP4694904A2
(en)
|
2023-04-13 |
2026-02-18 |
REGENXBIO Inc. |
Targeting aav capsids, methods of manufacturing and using same
|
|
WO2025017168A1
(en)
*
|
2023-07-19 |
2025-01-23 |
Genethon |
Novel optimized utrophin micro-genes
|